Report on Business Magazine Top 1000 - Company Snapshot

TEKMIRA PHARMACEUTICALS CORPORATION

TEKMIRA PHARMACEUTICALS CORPORATION is a biopharmaceutical company focused on novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners.

Address: Suite 100, 8900 Glenlyon Pkwy. , Burnaby, BC, V5J 5J8
Phone: 604 - 419-3200
Fax: 604 - 419-3201
Web Site:www.tekmira.com
E-Mail:bcousins@tekmira.com
CEO: Mark J. Murray, President & C.E.O.
CFO: Bruce Cousins, E.V.P. & C.F.O.
HR : N/A

LATEST ANNUAL FINANCIALS
Date of Balance Sheet: 31-Dec-2014
12 Months, US$
Total Revenue ($000): 19,933
% Change Revenue: 25.0
Profit/Loss ($000): -38,837
Employees: 103

GENERAL INFORMATION
Stock Symbol:
Exchanges:
Industry: BIOTECHNOLOGY & PHARMACEUTICAL
Company Type: DEFUNCT
Company Status: DEFUNCT


For more information on this company or any other North America publicly traded stock try globeinvestor.com.

© Copyright 2007 CTVglobemedia Publishing Inc. All Rights Reserved.
Last Updated 20-Jun-2015